mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
1 |